Quest for autism biomarkers faces steep statistical challenges
Finding a difference between people with and without autism is only the first step toward identifying a clinically useful marker of the condition.
Finding a difference between people with and without autism is only the first step toward identifying a clinically useful marker of the condition.
A new study casts doubt on the ‘extreme male brain’ theory of autism, Americans are worried about gene editing, and a Pasteur Institute clash raises questions about scientists’ age.
An autism researcher retracts her third paper in as many years, scientists write fraudulent reviews of their own papers, and Pokémon Go boosts social skills in children with autism.
Scientists are excluding U.K. colleagues from studies; a life sciences publisher abandons the ‘impact factor;’ and a new open-access journal makes its debut.
Autism researchers are leading the charge for open sharing of results before publication in peer-reviewed journals.
A new blood test could personalize depression treatment, a journalist dissects the demise of a large children’s study, and the National Institutes of Health budget may grow by $2 billion.
A training program leads physicians to screen more children for autism, psychotherapists may discriminate against the working class, and a lack of federal funding leaves children with autism underserved.
Proposed changes to federal ethics rules spark concerns among researchers, attention deficit hyperactivity disorder may be different in adults, and an artist plans to print a three-dimensional hand using stem cells.
An autism drug can cause compulsion problems, embryos survive a record 13 days in culture, and the results from some clinical trials languish for too long.